DocuSign Inc

DOCU

Equity

ISIN US2561631068 / Valor 41193881

NASDAQ (2024-11-21)

USD 80.15+1.70%

DocuSign Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

DocuSign Inc is a leading company in the electronic signature technology industry, offering a platform with over 400 prebuilt integrations with popular business apps and an API that allows embedding and connecting with customers' websites, mobile apps, and custom workflows. With more than 1,400,000 customers and users in over 180 countries, DocuSign helps organizations streamline the process of preparing, signing, acting on, and managing agreements. Since its founding in 2003, DocuSign has been dedicated to accelerating business processes and simplifying life for companies and individuals globally.

Summarized from source with an LLMView SourceSector: Technology

Total Revenue

DocuSign Inc. reported total revenue of $709.6 million for the first quarter of fiscal 2025, which represents a 7% increase year-over-year. This growth indicates a positive trend in the company's financial performance.

Subscription Revenue

In the first quarter of fiscal 2025, DocuSign Inc.'s subscription revenue reached $691.5 million, marking an 8% increase compared to the same period last year. This highlights the company's strong recurring revenue base.

Net Income

DocuSign Inc. achieved a GAAP net income per diluted share of $0.16 in the first quarter of fiscal 2025, compared to $0.00 in the same period last year. This improvement reflects better profitability and financial health.

Cash Flow

For the first quarter of fiscal 2025, DocuSign Inc. reported net cash provided by operating activities of $254.8 million, up from $233.6 million in the same period last year. Free cash flow also increased to $232.1 million from $214.6 million year-over-year.

Guidance

DocuSign Inc. provided guidance for the quarter ending July 31, 2024, with expected total revenue between $725 million and $729 million. The company also anticipates subscription revenue to be in the range of $705 million to $709 million, indicating continued growth.

Summarized from source with an LLMView Source

Key figures

88.6%1Y

-69.6%3Y

14.6%5Y

Performance

37.1%1Y

67.1%3Y

61.8%5Y

Volatility